The Mitsubishi Tanabe Pharma Group engages Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) across Europe.
In accordance with the EFPIA Code of Transfers of Value from Pharmaceutical Companies 2019, details of Transfers of Value made to HCPs and HCOs in Europe by the Mitsubishi Tanabe Pharma Group can be found below.
The methodology applied in preparing and collating this data is available here in English*, French* and German*.
If you are a Healthcare Professional and have any questions regarding the figures disclosed, please contact:
Finance@mt-pharma-eu.com.
2022 Transfers of Value
| Austria | |
|---|---|
| Research & Development | EUR 358,961.92 |
| Non-Research & Development | EUR 87,445.44 |
| Full details here | |
| Belgium | |
|---|---|
| Research & Development | EUR 48,923.15 |
| Non-Research & Development | EUR 42,186.18 |
| Full details here | |
| Bulgaria | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Croatia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Cyprus | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Czech Republic | |
|---|---|
| Research & Development | CZK 591,929.58 |
| Non-Research & Development | CZK 0.00 |
| Full details here | |
| Denmark | |
|---|---|
| Research & Development | EUR 2,406.30 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Estonia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Finland | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 800.00 |
| Full details here | |
| France | |
|---|---|
| Research & Development | EUR 760,493.64 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Germany | |
|---|---|
| Research & Development | EUR 1,128,128.96 |
| Non-Research & Development | EUR 59,799.10 |
| Full details here | |
| Greece | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Hungary | |
|---|---|
| Research & Development | HUF 563,835.00 |
| Non-Research & Development | HUF 0.00 |
| Full details here | |
| Ireland | |
|---|---|
| Research & Development | EUR 11,191.61 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Italy | |
|---|---|
| Research & Development | EUR 886,596.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Latvia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 3,600.00 |
| Full details here | |
| Lithuania | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Malta | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| The Netherlands | |
|---|---|
| Research & Development | EUR 100,275,847.45 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Norway | |
|---|---|
| Research & Development | EUR 16,307.76 |
| Non-Research & Development | EUR 10,000.00 |
| Full details here | |
| Poland | |
|---|---|
| Research & Development | EUR 155,394.47 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Portugal | |
|---|---|
| Research & Development | EUR 139,785.77 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Romania | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Russia | |
|---|---|
| Research & Development | EUR 191,586.81 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Serbia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Slovakia | |
|---|---|
| Research & Development | EUR 14,188.90 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Slovenia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Spain | |
|---|---|
| Research & Development | EUR 645,591.08 |
| Non-Research & Development | EUR 1,600.00 |
| Full details here | |
| Sweden | |
|---|---|
| Research & Development | SEK 282,167.20 |
| Non-Research & Development | SEK 33,459.90 |
| Full details here | |
| Switzerland | |
|---|---|
| Research & Development | CHF 4,458.35 |
| Non-Research & Development | CHF 115,384.73 |
| Full details here | |
| Turkey | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Ukraine | |
|---|---|
| Research & Development | EUR 151,851.48 |
| Non-Research & Development | EUR 101,483.00 |
| Full details here | |
| United Kingdom | |
|---|---|
| Research & Development | GBP 300,330.79 |
| Non-Research & Development | GBP 22,339.50 |
| Full details here or here (ABPI Website) | |
* The Mitsubishi Tanabe Pharma Group has established legal entities in the United Kingdom, Germany and Switzerland and therefore disclosure is made according to local requirements for these countries
Terms and Privacy
Contact Us
Mitsubishi TANABE Pharma Europe Ltd
Dashwood House
69 Old Broad Street
London
EC2M 1QS
United Kingdom